ATE378351T1 - Therapeutische impfzusammensetzung zur verhütung und behandlung von erkrankungen bei säugetieren - Google Patents

Therapeutische impfzusammensetzung zur verhütung und behandlung von erkrankungen bei säugetieren

Info

Publication number: ATE378351T1
Authority: AT; Austria
Prior art keywords: mammals; preventing; therapeutic vaccine; vaccine composition; treating diseases
Prior art date: 2001-09-14

Application number

AT02785499T

Other languages

English (en)

Inventor

Gerard Papierok

Serge Vincens

Original Assignee

Oridan Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-09-14

Filing date

2002-09-13

Publication date

2007-11-15

2002-09-13 Application filed by Oridan Inc filed Critical Oridan Inc

2007-11-15 Application granted granted Critical

2007-11-15 Publication of ATE378351T1 publication Critical patent/ATE378351T1/de

Links

241000124008 Mammalia Species 0.000 title abstract 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
229940021747 therapeutic vaccine Drugs 0.000 title abstract 2
201000010099 disease Diseases 0.000 title 1
125000003275 alpha amino acid group Chemical group 0.000 abstract 2
108090000765 processed proteins & peptides Proteins 0.000 abstract 2
241000282421 Canidae Species 0.000 abstract 1
241000283086 Equidae Species 0.000 abstract 1
241000282323 Felidae Species 0.000 abstract 1
206010020751 Hypersensitivity Diseases 0.000 abstract 1
239000002671 adjuvant Substances 0.000 abstract 1
208000026935 allergic disease Diseases 0.000 abstract 1
210000004027 cell Anatomy 0.000 abstract 1
230000003111 delayed effect Effects 0.000 abstract 1
230000009610 hypersensitivity Effects 0.000 abstract 1
230000036039 immunity Effects 0.000 abstract 1
210000004698 lymphocyte Anatomy 0.000 abstract 1
230000001404 mediated effect Effects 0.000 abstract 1
230000001681 protective effect Effects 0.000 abstract 1
230000004044 response Effects 0.000 abstract 1
230000000638 stimulation Effects 0.000 abstract 1
229960005486 vaccine Drugs 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/5555—Muramyl dipeptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Immunology (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Urology & Nephrology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biomedical Technology (AREA)
Biochemistry (AREA)
Hematology (AREA)
Food Science & Technology (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Analytical Chemistry (AREA)
Physics & Mathematics (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Microbiology (AREA)
Biotechnology (AREA)
Cell Biology (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AT02785499T 2001-09-14 2002-09-13 Therapeutische impfzusammensetzung zur verhütung und behandlung von erkrankungen bei säugetieren ATE378351T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR0111942A FR2829767B1 (fr)	2001-09-14	2001-09-14	Composes peptidiques destines a la prevention et au traitement d'affections chez les mammiferes

Publications (1)

Publication Number	Publication Date
ATE378351T1 true ATE378351T1 (de)	2007-11-15

Family

ID=8867311

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT02785499T ATE378351T1 (de)	2001-09-14	2002-09-13	Therapeutische impfzusammensetzung zur verhütung und behandlung von erkrankungen bei säugetieren

Country Status (8)

Country	Link
US (1)	US20050079186A1 (de)
EP (1)	EP1425301B1 (de)
AT (1)	ATE378351T1 (de)
AU (1)	AU2002350800A1 (de)
DE (1)	DE60223564D1 (de)
ES (1)	ES2297025T3 (de)
FR (1)	FR2829767B1 (de)
WO (1)	WO2003025012A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2842813B1 (fr) *	2002-07-26	2007-06-01	Bio Veto Tests Bvt	ANTICORPS D'ISOTYPES PARTICULIERS ANTI ANTIGENES D'EXCRETION SECRETION DE PROMASTIGOTES OU D'AMASTIGOTES DE Leishmania sp
FR2844511B1 (fr) *	2001-09-14	2007-12-28	Oridan Inc	Composes peptidiques destines a la prevention et au traitement d'affections chez les mammiferes
US7266395B2 (en)	2003-10-30	2007-09-04	Research In Motion Limited	System and method of wireless proximity awareness
FR2915397B1 (fr) *	2007-04-27	2012-01-20	Vincience	Composition pharmaceutique et/ou cosmetique contenant des principes actifs activateurs de l'aconitase
FR2932802B1 (fr) *	2008-06-19	2010-08-20	Oridan Inc	Peptide de synthese non natif cyclise et complexe de peptides comprenant ledit peptide cyclise, destine a induire et a caracteriser la prevention ou le traitement d'affections chez les mammiferes
BRPI0804859B1 (pt) *	2008-08-22	2021-11-03	Universidade Federal De Minas Gerais	Peptídeos sintéticos para a obtenção de polímero proteíco para imunização contra leishmaniose, produtos e seus usos
WO2012139094A2 (en)	2011-04-08	2012-10-11	H. Lee Moffitt Cancer Center And Research Institute, Inc.	Method of developing a vaccine using peptide-poly ic complexes
US10000538B2 (en)	2011-05-09	2018-06-19	Laboratorios Leti, S.L.	Molecule for treating an inflammatory disorder

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1997048725A1 (en) *	1996-06-21	1997-12-24	Peptech Limited	Novel peptides for prevention and treatment of infection

2001
- 2001-09-14 FR FR0111942A patent/FR2829767B1/fr not_active Expired - Fee Related
2002
- 2002-09-13 EP EP02785499A patent/EP1425301B1/de not_active Expired - Lifetime
- 2002-09-13 AT AT02785499T patent/ATE378351T1/de not_active IP Right Cessation
- 2002-09-13 DE DE60223564T patent/DE60223564D1/de not_active Expired - Lifetime
- 2002-09-13 WO PCT/FR2002/003134 patent/WO2003025012A2/fr not_active Ceased
- 2002-09-13 ES ES02785499T patent/ES2297025T3/es not_active Expired - Lifetime
- 2002-09-13 US US10/489,586 patent/US20050079186A1/en not_active Abandoned
- 2002-09-13 AU AU2002350800A patent/AU2002350800A1/en not_active Abandoned

Also Published As

Publication number	Publication date
FR2829767A1 (fr)	2003-03-21
ES2297025T3 (es)	2008-05-01
EP1425301B1 (de)	2007-11-14
FR2829767B1 (fr)	2004-02-27
WO2003025012A2 (fr)	2003-03-27
WO2003025012A3 (fr)	2003-12-11
EP1425301A2 (de)	2004-06-09
US20050079186A1 (en)	2005-04-14
AU2002350800A1 (en)	2003-04-01
DE60223564D1 (de)	2007-12-27

Similar Documents

Publication	Publication Date	Title
NO933126D0 (no)	1993-09-02	Loeselige ligander for cd40
PT1409692E (pt)	2008-12-26	Novos péptidos do derivados da proteína g do vírus respiratório sincicial (vrs) e sua utilização numa vacina
DE602004024542D1 (de)	2010-01-21	Untereinheit-impfstoff gegen das respiratorische synzytialvirus
WO2004030608A3 (en)	2005-03-10	Nanoemulsion vaccines
EP1471936A4 (de)	2006-10-25	Hiv-vakzine und anwendungsverfahren
ATE378351T1 (de)	2007-11-15	Therapeutische impfzusammensetzung zur verhütung und behandlung von erkrankungen bei säugetieren
CY1107784T1 (el)	2013-06-19	Πρωτεϊνη συντηξης g του ihnv για διεγερση του ανοσοποιητικου συστηματος
KR20040078639A (ko)	2004-09-10	카세인 유도 펩타이드 및 이들의 치료 용도
UA83989C2 (ru)	2008-09-10	Выделенный пептид, который стимулирует противоопухолевый иммунный ответ, фармацевтическая композиция на его основе и ее применение
ES2502366T3 (es)	2014-10-03	Inducción de inmunidad tumoral por variantes de proteína de unión a folato
WO2004022092A3 (en)	2004-04-29	Flagellin peptides as adjuvants for vaccines
DE602006014720D1 (de)	2010-07-15	Immunstimulatorische kombination zur vorbeugung und behandlung von hepatitis c
DE60131975D1 (de)	2008-01-31	Anwendung des herpes simplex virus glykoproteins-d zur unterdrückung von immunantworten
ATE353226T1 (de)	2007-02-15	Adjuvanszusammensetzung enthaltend fha oder ein fha-fragment in freier form
ATE552269T1 (de)	2012-04-15	Zykliertes, nichtnatives synthetisches peptid und peptidkomplex mit besagtem zykliertem peptid zur veranlassung und charakterisierung der vorbeugung oder behandlung von störungen bei säugetieren
WO2003064446A3 (en)	2004-04-01	Plasma protein-binding peptides from bacterial curli
ATE145335T1 (de)	1996-12-15	Kreuzreaktive immunisierung gegen influenza
EA200400534A1 (ru)	2004-12-30	Стимуляция тимозином генетической иммунизации
ES2171360B1 (es)	2003-12-16	Vacuna para la proteccion de animales frente a la leishmania.
ATE374040T1 (de)	2007-10-15	Nukleoprotein des toscanavirus
HK1075842A (en)	2005-12-30	Nanoemulsion vaccines
ATE357253T1 (de)	2007-04-15	Immunogene zusammensetzungen die ein antigen und ein m protein des respiratorischen synzytialviruses enthalten
CY1115126T1 (el)	2016-12-14	Μεθοδος και εμβολιο που περιλαμβανει συμπολυμερες 1 για θεραπεια ψυχιατρικων διαταραχων

Legal Events

Date	Code	Title	Description
2008-05-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties